Metrics as of 10/15/2026, 11:32 PM (Berlin time), refresh in progress.
Alphatec Holdings Stock
Alphatec Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Patrick S. Miles
- Employees
- 913
- Market cap
- $1.7 B
- IPO
- 01/06/2006
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Established in 1990, the company is headquartered in Carlsbad, USA. Within the Healthcare sector, specifically in the Medical - Devices industry, Alphatec Holdings…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Alphatec Holdings stock: price history
1D
-1.1%
1W
+1.3%
1M
+3.0%
6M
-2.6%
YTD
-48.6%
1Y
-24.2%
2Y
+88.1%
5Y
-11.3%
10Y
+64.3%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~60% stronger price swings than usual
Ask the agents about Alphatec Holdings
Analyst assessment of Alphatec Holdings
PRICE TARGET LOW
US$12.00
CONSENSUS
US$16.22
MEDIAN
US$15.00
PRICE TARGET HIGH
US$24.00
0
STRONG BUY
17
BUY
2
HOLD
1
SELL
0
STRONG SELL
20
TOTAL · Buy
As of: 05/08/2026
Alphatec Holdings stock metrics
P/E
-14.96
P/B
-138.61
EV/EBITDA
159.69
RETURN ON EQUITY
213.6%
NET MARGIN
-12.1%
DEBT/EQUITY
-50.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
78.2%
FLOAT SHARES
120,781,300
AVG. DAILY VOLUME (30D)
2,362,557
Insider transactions (SEC)
Carls Thomas Andrew
Miles Patrick
Marshall Tyson Eliot
Berkowitz Mortimer III
Demski David M
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Alphatec Holdings stock
What does Alphatec Holdings do?
Alphatec Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Patrick S. Miles, the company employs around 913 people.
The IPO was on 01/06/2006; the stock trades on NASDAQ under the ticker ATEC.
What do analysts say about Alphatec Holdings stock?
20 analysts rate the stock, the consensus is Buy (as of 05/08/2026).
The average price target is US$16.22, ranging from US$12.00 to US$24.00, with a median of US$15.00.
This is an external assessment, not a statement by Market Jury.
When does Alphatec Holdings report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 60% stronger than usual.
Does Alphatec Holdings pay a dividend?
No, Alphatec Holdings currently does not pay a dividend.
Which stocks are comparable to Alphatec Holdings?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Alphatec Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alphatec Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.